Product Specifications Research Overview TB-500 is the research-market designation for synthetic thymosin beta 4 (T4), a 43-residue, N-terminally acetylated polypeptide with molecular formula CHNOS, molecular weight 4963.4 g/mol and CAS number 77591-33-4
If orforglipron is approved along with Novo Nordisk's oral Wegovy (see Oral Wegovy), there will be two oral GLP-1 therapies available in 2026
For a broader look at the hormone itself, What is GLP-1 and How Does It Work
Both contain the same total amount of Retatrutide at the same purity
Week 2: nutritional optimization Goal: Address protein and micronutrient deficiencies
This guide breaks down the testing data, the availability timeline, the quality concerns, and the alternatives